A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes-Reference-Cited by-同舟云学术

A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes

Published:2015-09-03 Issue:6 Volume:41 Page:1227-1236
ISSN:0586-7614
Container-title:Schizophrenia Bulletin
language:en
Short-container-title:SCHBUL

Author:

Robinson Delbert G.,Gallego Juan A.,John Majnu,Petrides Georgios,Hassoun Youssef,Zhang Jian-Ping,Lopez Leonardo,Braga Raphael J.,Sevy Serge M.,Addington Jean,Kellner Charles H.,Tohen Mauricio,Naraine Melissa,Bennett Natasha,Greenberg Jessica,Lencz Todd,Correll Christoph U.,Kane John M.,Malhotra Anil K.

Publisher

Oxford University Press (OUP)

Subject

Psychiatry and Mental health

Reference25 articles.

1. Pharmacological Treatments for First-Episode Schizophrenia

2. Prescription Practices in the Treatment of First-Episode Schizophrenia Spectrum Disorders: Data From the National RAISE-ETP Study

3. Cardiometabolic Risk in Patients With First-Episode Schizophrenia Spectrum Disorders

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An overview of the efficacy and safety of brexpiprazole for the treatment of schizophrenia in adolescents;Expert Review of Neurotherapeutics;2024-07-05

2. Comparative analysis of third-generation antipsychotics in first-episode schizophrenia: efficacy, safety, and cognitive impacts. A narrative review;International Clinical Psychopharmacology;2024-06-14

3. Racial Disparities Among Clinical High-Risk and First-Episode Psychosis Multisite Research Participants: A Systematic Review;Psychiatric Services;2024-05-01

4. Safety outcomes of antipsychotics classes in drug-naïve patients with first-episode schizophrenia: A nationwide cohort study in South Korea;Asian Journal of Psychiatry;2024-01

5. Efficacy and Tolerance of Antipsychotics Used for the Treatment of Patients Newly Diagnosed with Schizophrenia: A Systematic Review and Meta-Analysis;Pharmacy;2023-11-10